2020
DOI: 10.1111/tme.12738
|View full text |Cite
|
Sign up to set email alerts
|

Transfusion in critical care: Past, present and future

Abstract: Anaemia and coagulopathy are common in critically ill patients and are associated with poor outcomes, including increased risk of mortality, myocardial infarction, failure to be liberated from mechanical ventilation and poor physical recovery. Transfusion of blood and blood products remains the corner stone of anaemia and coagulopathy treatment in critical care. However, determining when the benefits of transfusion outweigh the risks of anaemia may be challenging in some critically ill patients. Therefore, the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 136 publications
(215 reference statements)
0
4
0
Order By: Relevance
“…If the critical Hb level is reached, compensatory physiological responses to anemia are unable to maintain tissue oxygenation [42]. A further decline in Hb concentration will, therefore, lead to a decrease in the delivery of oxygen and oxygen consumption [43]. It has been suggested that the critical Hb level is not only patient-and disease-dependent but can also vary over time, as the compensatory responses to anemia may be affected by different comorbidities.…”
Section: Discussionmentioning
confidence: 99%
“…If the critical Hb level is reached, compensatory physiological responses to anemia are unable to maintain tissue oxygenation [42]. A further decline in Hb concentration will, therefore, lead to a decrease in the delivery of oxygen and oxygen consumption [43]. It has been suggested that the critical Hb level is not only patient-and disease-dependent but can also vary over time, as the compensatory responses to anemia may be affected by different comorbidities.…”
Section: Discussionmentioning
confidence: 99%
“… 1 Despite the beneficial effects of an RBC transfusion, infectious and non-infectious complications may develop, meaning that patient safety must be ensured by using blood products appropriately. 2 The immunomodulatory effects of RBC transfusion may result in a higher incidence of nosocomial infections. 3 Furthermore, these products are expensive resources with limited availability; red blood cell (RBC) transfusions cost $500-1200 per unit.…”
Section: Introductionmentioning
confidence: 99%
“…In critically ill patients, anemia and coagulopathy are common and associated with poor outcomes, such as increased risk of mortality, myocardial infarction, and thrombosis [29]. Transfusion of blood and blood products remains a cornerstone of anemia and coagulopathy treatment in critical care.…”
Section: Introductionmentioning
confidence: 99%